Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 9,967,852 | 8,674,505 | 8,826,014 | 7,698,354 | 8,790,127 |
| Cost of Goods | 4,045,041 | 3,741,116 | 3,543,932 | 3,335,104 | 3,784,224 |
| Gross Profit | 5,922,811 | 4,933,389 | 5,282,082 | 4,363,250 | 5,005,905 |
| Operating Expenses | 4,092,901 | 3,752,320 | 3,677,048 | 2,892,871 | 3,142,318 |
| Operating Income | 1,829,947 | 1,181,185 | 1,605,966 | 1,470,483 | 1,863,809 |
| Interest Expense | 151,344 | 149,102 | 134,488 | 118,201 | 162,298 |
| Other Income | 89,227 | 32,027 | 87,209 | -30,075 | 121,371 |
| Pre-tax Income | 1,767,830 | 1,064,110 | 1,558,687 | 1,322,207 | 1,822,882 |
| Income Tax | 326,983 | 173,450 | 267,037 | 319,192 | 284,153 |
| Net Income Continuous | 1,440,847 | 890,660 | 1,291,650 | 1,003,015 | 1,538,729 |
| Net Income | $1,440,847 | $890,660 | $1,291,650 | $1,003,015 | $1,538,729 |
| EPS Basic Total Ops | 0.92 | 0.58 | 0.83 | 0.65 | 1.00 |
| EPS Basic Continuous Ops | 0.93 | 0.58 | 0.84 | 0.65 | 0.99 |
| EPS Diluted Total Ops | 0.92 | 0.57 | 0.83 | 0.64 | 0.99 |
| EPS Diluted Continuous Ops | 0.93 | 0.57 | 0.83 | 0.64 | 0.99 |
| EBITDA(a) | $2,539,528 | $1,858,209 | $2,281,168 | $2,032,984 | $2,411,162 |